DUBLIN–(BUSINESS WIRE)–The “Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size, Share & Trends Analysis Report by Service Type (In-house, Contract Outsourcing), by Synthesis Type, by Product, by Region, and Segment Forecasts, 2021-2028” report has been added to ResearchAndMarkets.com’s offering.
The global veterinary active pharmaceutical ingredients manufacturing market size is expected to reach USD 10.4 billion by 2028., expanding at a CAGR of 6.9% over the forecast period. The increasing prevalence of chronic diseases in animals and growing concerns among pet owners are the key contributors to the market growth.
Moreover, the growing prevalence of zoonotic diseases is driving the demand for drugs, which, in turn, boosts the demand for active pharmaceutical ingredients (APIs) for the production of these drugs. According to the Centers for Disease Control and Prevention (CDC), in July 2017, it was estimated that 6 out of 10 known infectious diseases in people can be transmitted from animals and 3 out of every 4 novel or emerging infectious diseases in people are caused due to animals.
Government organizations are involved in issuing various guidelines to promote veterinary services globally, which is expected to contribute to market growth in the coming years. For instance, in May 2018, the OIE International Standards, a part of the WTO framework, issued standards to improve animal health, which will affect human health as well. One of the key challenges was found to be the lack of technical expertise in this field.
The rising number of veterinarians is also anticipated to boost the market growth. According to the American Veterinary Medical Association, in 2018, there were 113,394 veterinarians in the U.S. as compared to 110,531 veterinarians in 2017. Out of these, 48,898 were involved in private clinical practice exclusively for companion animals. Also, according to the Canadian Veterinary Medical Association (CVMA), the approximate number of veterinarians in Canada is 12,921.
Veterinary API Manufacturing Market Report Highlights
- The contract outsourcing service type accounted for the largest revenue share of over 58% in 2020 owing to associated benefits with its usage
- The growing number of outsourcing activities by pharmaceutical companies is expected to boost the segment growth
- Chemical-based API synthesis type dominated the market in 2020. This can be attributed to its high usage by many major manufacturing companies
- The vaccines product segment held the largest market share of over 23% in 2020 due to increased demand for vaccines as a result of a high prevalence of chronic diseases in animals
- Due to the presence of well-established companies and technologically advanced infrastructure, North America dominated the market in 2020
- However, Asia Pacific is anticipated to register the fastest CAGR over the forecast period owing to the high potential and rapidly growing markets of India, Japan, and China
-
Industry players are involved in strategies including mergers & acquisitions, collaborative agreements, and geographic expansions to gain a competitive edge
Key Topics Covered:
Chapter 1 Methodology and Scope
Chapter 2 Executive Summary
Chapter 3 Veterinary API manufacturing Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.2 Penetration & Growth Prospect Mapping
3.3 Pricing Analysis
3.4 Veterinary API Manufacturing Market Dynamics
3.5 PEST Analysis
3.6 Forecast Analysis
Chapter 4 Veterinary API manufacturing Market: Segment Analysis, By Service Type, 2016 – 2028 (USD Million)
Chapter 5 Veterinary API manufacturing Market: Segment Analysis, By Synthesis Type, 2016 – 2028 (USD Million)
Chapter 6 Veterinary API manufacturing Market: Segment Analysis, By Product, 2016 – 2028 (USD Million)
Chapter 7 Veterinary API manufacturing Market: Regional Market Analysis, By Service Type, Synthesis Type, and By Product 2016 – 2028 (USD Million)
Chapter 8 Veterinary API manufacturing Market: Competitive Analysis
8.1 Market Participation Categorization
8.2 Company Market Share/Position Analysis, 2020
8.3 Recent Developments & Impact Analysis, By Key Market Participants
Chapter 9 Competitive Landscape
- Alivira Animal Health Limited
- Excel Industries Ltd
- Ofichem Group
- Shaanxi Hanjiang Pharmaceutical Group Co.,Ltd.
- Menadiona
- Afton Pharma
- Jiangsu Lingyun Pharmaceutical Co., Ltd.
- SUANFARMA
- NGL Fine-Chem Ltd.
- FIS – Fabbrica Italiana Sintetici S.p.A
For more information about this report visit https://www.researchandmarkets.com/r/rchfs1
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900